Ready-to-Use Multiplex Assays: Twelve qPCR vials (5-plex format) optimized for consistent and sensitive amplification.
Built-in Internal Amplification Control (Cy5.5): Every 5-plex mix includes an Internal Control detected on the Cy5.5 channel, ensuring real-time monitoring of amplification performance and PCR inhibition.
Positive Control: Whole genome libraries Normalized to 500 genomic copies/ul
Exogenous Control (EC): Spike-in Non-Pathogen Whole organism controls to confirm extraction and amplification efficiency.
Comprehensive Documentation: Includes detailed protocols, troubleshooting guide, and Certificate of Analysis (COA).
Comprehensive Detection of UTI, Urogenital, STI, and Antimicrobial Resistance Targets
- Bacterial Targets: Acinetobacter baumannii, Bacterial Vaginosis–Associated Bacterium 2 (BVAB2), Citrobacter freundii/braakii/koseri, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Gardnerella vaginalis, Haemophilus ducreyi, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella (Enterobacter) aerogenes, Morganella morganii, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae (NG), Prevotella bivia, Proteus mirabilis, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus saprophyticus, Streptococcus agalactiae (Group B), Streptococcus pyogenes (Group A), Treponema pallidum, Ureaplasma urealyticum/parvum, Chlamydia trachomatis (CT) - genome pmpC / cryptic plasmid ORF1
- Parasitic Targets: Trichomonas vaginalis (TV)
- Viral Targets: Herpes Simplex Virus 1 (HSV-1), Herpes Simplex Virus 2 (HSV-2)
- Fungal Targets: Candida albicans, Candida auris, Candida dubliniensis, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis
- AMR: Beta-lactamase (CTX-M Group 1), Class A/B carbapenemase (blaKPC / blaNDM), Fluoroquinolone resistance (qnrA / qnrB / qnrS), Methicillin resistance (mecA), Sulfonamide resistance (sul1 / sul2 / sul3), Tetracycline resistance (tetB), Trimethoprim resistance (dfrA1 / dfrA5 / dfrA7 / dfrA12 / dfrA17), Vancomycin resistance (VanA / VanB / VanM)
- Controls: Internal Control (RNase P), Exogenous Control (EC)
Covers 28 bacterial targets, 7 fungal targets, 2 viral targets, 1 parasitic target, 8 antimicrobial resistance markers, and 2 internal controls for comprehensive UTI, urogenital infection, STI detection, and antimicrobial resistance profiling.
